Fibriant awarded Euro 16.5M EIC Accelerator funding to support RECOFIB development
Leiden, The Netherlands, 23 December 2021 – Fibriant, a scale-up biotech company focused onthe development of the RECOFIB platform, was […]
Leiden, The Netherlands, 23 December 2021 – Fibriant, a scale-up biotech company focused onthe development of the RECOFIB platform, was […]
Leiden, The Netherlands, December 5, 2019 – Fibriant B.V., a developer of innovative recombinant fibrin(ogen) technology and products, today announced […]
Fibriant will provide an up-date on the progress with the development of their recombinant Fibrinogen technology platform and the product […]
Prof. Flick, a leader in the field of Fibrinogen and host-defense, will present, also on behalf of Fibriant, new data […]
Fibriant and Biomed Elements have entered into a research collaboration, combining their fibrinogen and biopolymer technologies, to develop a topical […]